6
Oct
2026

Yuxi Walvax Biotechnology Co., Ltd.

Exhibitor at CPHI Milan 2026 stand 20K17, Finished Dosage & Formulation
About Us

Founded in 2001, Walvax Biotechnology Co. Ltd. is mainly engaged in research and development, manufacturing and distribution of safe and efficacious human vaccines. Walvax is a leading public listed company in China and has successfully developed 9 licensed vaccines (13 presentations). Among the 9 licensed products, Walvax has world’s 2nd approved PCV-13, 4th approved mRNA Covid-19 vaccine and 5th approved HPV vaccine. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20K17, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026